Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px
Document › Details

ADC Therapeutics S.A.. (8/3/21). "Press Release: ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates". Lausanne.

Organisations Organisation ADC Therapeutics S.A. (NYSE: ADCT)
  Group ADC Therapeutics (Group)
  Organisation 2 FDA (US Food and Drug Administration)
  Group United States (govt)
Products Product loncastuximab tesirine-lpyl (ADCT-402)
  Product 2 antibody-drug conjugate (ADC)
Persons Person Martin, Chris (Auven Therapeutics 201506 CEO of ADC Therapeutics before CEO of Spirogen Ltd)
  Person 2 Müller, Alexandre (Dynamics Group 202104)
     


   
Record changed: 2022-02-05

Advertisement

Picture [iito] Fighting Customers 650x100px

More documents for ADC Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px




» top